These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34534672)
1. Effectiveness of inhalation technique assessment service for patients with Respimat® inhaler. Rossi V; Salimäki J; Sandler C; Airaksinen M; Kauppi P Pulm Pharmacol Ther; 2021 Dec; 71():102077. PubMed ID: 34534672 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a structured pharmacist-led inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. Ruud KW; Rønningen SW; Faksvåg PK; Ariansen H; Hovland R Patient Educ Couns; 2018 Oct; 101(10):1828-1837. PubMed ID: 29805072 [TBL] [Abstract][Full Text] [Related]
3. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices. Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112 [TBL] [Abstract][Full Text] [Related]
4. Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. Zhang W; Xu L; Gao S; Ding N; Shu P; Wang Z; Li Y Int J Chron Obstruct Pulmon Dis; 2020; 15():1471-1479. PubMed ID: 32606655 [TBL] [Abstract][Full Text] [Related]
5. Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Tschacher A; Cadus C; Schildge S; Diedrich JP; Chhajed PN; Leuppi-Taegtmeyer AB; Leuppi JD Curr Med Res Opin; 2021 Nov; 37(11):2019-2033. PubMed ID: 34433362 [TBL] [Abstract][Full Text] [Related]
6. First-time handling of different inhalers by chronic obstructive lung disease patients. Harb HS; Laz NI; Rabea H; Abdelrahim MEA Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625 [No Abstract] [Full Text] [Related]
7. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler. Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465 [TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD. Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871 [TBL] [Abstract][Full Text] [Related]
9. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease. Kässner F; Hodder R; Bateman ED Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628 [TBL] [Abstract][Full Text] [Related]
10. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler. Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941 [TBL] [Abstract][Full Text] [Related]
11. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients. Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B Respiration; 2000; 67(3):306-14. PubMed ID: 10867600 [TBL] [Abstract][Full Text] [Related]
12. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique. Brand P; Hederer B; Austen G; Dewberry H; Meyer T Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey. Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137 [TBL] [Abstract][Full Text] [Related]
14. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD]. Henriet AC; Marchand-Adam S; Mankikian J; Diot P Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393 [TBL] [Abstract][Full Text] [Related]
15. Reduced Environmental Impact of the Reusable Respimat Hänsel M; Bambach T; Wachtel H Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391 [TBL] [Abstract][Full Text] [Related]